Cagrilintide specifications & batch documentation
Review Cagrilintide in 5 mg and 10 mg vial formats, with 10 vials per box. Select the catalog code and pack specification for your wholesale inquiry. Our team confirms current availability, batch documentation and destination requirements.
Build your inquiry
Availability, packaging and pricing are confirmed by our team.Cagrilintide specifications and packaging
| Catalog code | Product / composition | Pack specification |
|---|---|---|
| CGL5 | Cagrilintide | 5 mg × 10 vials |
| CGL10 | Cagrilintide | 10 mg × 10 vials |
Each listed pack contains 10 vials. Select the catalog code and specification above, then add your box quantity to the inquiry.
Cagrilintide batch documentation
For a Cagrilintide synthetic peptide inquiry, identify the catalog format first: CGL5 is 5 mg per vial and CGL10 is 10 mg per vial, each with 10 vials per box. Request available documentation for the specific batch proposed in the quotation.
Which documents should I request?
Ask our team to confirm whether a COA is available for the proposed supply batch and which identity, purity or content results it includes. Additional test reports are supplied only where available for that batch. We confirm document availability and scope before you rely on them for procurement.
Full reports are shared on request. Contact our team for the relevant document or access code. A public summary or a report for another sample does not establish the results of your proposed batch.
What to check in the documents
- Material identity: match the complete Cagrilintide material description and supplied form to the specification.
- Batch reference: compare the batch or lot identifier on the report, vial label and proposed supply. CGL5 and CGL10 are catalog codes, not batch numbers.
- Test scope: review the stated method, result, units and acceptance criteria for each reported test. A label quantity does not establish measured content or purity.
- Report details: check the report identifier, issuing laboratory and test date where provided. Ask for clarification if information needed for your procurement review is absent.
Request documents for your specification
Include CGL5 or CGL10, the number of boxes and your required document scope. For bulk material, include the total mass and material specification separately. Ask which available COA applies to the proposed supply batch before confirming the order.
Request Cagrilintide COA →Use the COA verification checklist · Prepare a wholesale inquiry
SPECIFICATION-SPECIFIC DOCUMENT REQUEST
Request your Cagrilintide batch COA
Select CGL5 or CGL10 and your box quantity above. The request link carries your selection into the COA form. Add your work email and any batch reference or testing requirements; our team will confirm the relevant documents.
Selected: Cagrilintide · 5 mg × 10 vials · CGL5 · 1 box.
Is a catalog code the same as a batch number?
No. CGL5 and CGL10 identify the catalog format. The report and proposed supply need a matching batch or lot reference.
Does the vial quantity show the tested content?
No. The listed 5 mg or 10 mg is the catalog label quantity. Review the method, units and results in the relevant batch document for measured content or purity.
Can I use a raw-material COA for finished vials?
Confirm which sample and supply stage the report covers. A raw-material report should not be treated as testing of finished vials without documentation connecting the report to the supplied item. For bulk sourcing, use the Cagrilintide raw-material page.
Cagrilintide purchasing details
Select the catalog format
CGL5 and CGL10 are the standalone Cagrilintide catalog options. Specify the individual product and box count when it is part of a larger multi-product inquiry.
Quantity example: CGL5 lists 5 mg per vial and 10 vials per box. An inquiry for 2 boxes means 20 vials at 5 mg each. These are catalog label quantities, not batch assay results.
Vials or bulk raw material?
The quote selector on this page uses boxes of finished vials. For bulk Cagrilintide raw-material requirements, specify the required total mass, material specification and container requirements separately; the vial pack does not establish a raw-material minimum order quantity.
Documents and quotation scope
Match the full material identity and any salt designation to the proposed batch. Request available identity and content documentation for the selected vial format. Use the COA review checklist to record the product, batch and test scope.
Send the selected code, box count, destination country and requested delivery date. Ask the quote to confirm availability, minimum quantity, preparation time, shipping service and cost. If custom labels or boxes are needed, include them in the packaging inquiry. Delivery timing and batch documents are confirmed for the proposed order. The supplier checklist covers the wider purchasing review.
PRODUCT IDENTITY & REFERENCE
Cagrilintide: modified peptide reference
The Cagrilintide reference includes a peptide chain, a lipid-bearing modification and a disulfide linkage. These features distinguish the complete molecule from an unmodified peptide backbone or a synthetic intermediate.
- Reference formula
- C194H312N54O59S2
- Reference molecular weight
- 4409 g/mol
- Reference record
- PubChem CID 171397054 ↗
Confirm the complete modified structure
Match the sequence, lipid attachment and disulfide connectivity in the material specification. A structure from a combination-product record should not be substituted for the single-component reference.
What to confirm for this catalog item
CGL5 and CGL10 are standalone Cagrilintide listings. No Semaglutide content or combination ratio is implied by those catalog codes; any combination must be specified separately.
Images and numerical properties describe the cited database forms, not batch test results. Confirm the actual supplied form against the specification. Molecular weights retain the precision reported by PubChem.
Related product details: Semaglutide · Retatrutide
Reference review: 28 September 2026. Pack details follow the catalog above; batch information is confirmed separately.